Monday, November 23, 2009

Reform Tax Would Hit H1N1 Vaccine Manufacturers


In an attempt to illustrate the real world consequences of reform's taxes, Senate Republicans are pointing out a provision that would tax the makers of swine flu vaccines and drugs. The provision raises $2.3 billion annually from drug makers who sell their products through government programs.

“When everybody is coming together to fight a possible pandemic the last thing the government should be doing is taxing the people who manufacture the vaccines and the drugs to treat H1N1 flu,” said a Senate Republican leadership aide.

Blog Archive